Circulating Tumor Cells (CTCs) are gaining huge popularity as a cancer biomarker. CTCs are detached from primary tumor to blood and circulate through the body resulting in metastasis. Our 1-drop blood test can detect CTCs in blood with highest sensitivity with just one drop of blood in a cancer patient. The number of CTCs in the blood can give information regarding the stage of cancer and further modalities for personalized treatment. The test is a minimally invasive rapid diagnostics test which costs approximately Rs:2000 for a single test. The CTCs detected/isolated will be sent directly to reputed hospitals for further treatment procedures with patient’s permission. This test will reduce not only the cost and duration but also the painful procedures used for sample collection from patients.
1- Drop Test
AI Care
The future of ‘standard’ medical care will be here sooner than anticipated, where a patient could see a smart phone or computer before consulting a doctor. AI and virtual reality is changing the definition of modern diagnostics. We provide a digital platform namely AI Care for diagnosing diseases from radiological and histopathological images. We are using a combination of multiple data sources in assessing a disease or its progression. MRI scanning, CT scanners, and X-rays offer non-invasive insights into the internal working of the human body. Artificial intelligence will enable the next generation of radiology tools that are accurate and detailed enough to replace the need for tissue samples in most of the cases.